Skip to content
AnalystLens

ALLSTATE CORP 8-K Report, Financial Results (Jul 30, 2025)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed July 30, 2025
Period End
July 30, 2025
In the record · 2016–202610-K1110-Q328-K240

ALL filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 240 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’16Nov ’16
  2. Deal closed8-K · Jan ’21Jan ’21
  3. Leadership change8-K · Aug ’22Aug ’22
  4. Leadership change8-K · Jul ’26Jul ’26

Summary

Summary of the 8-K filed July 30, 2025. Cited figures are marked; the original filing is the authoritative source.

Allstate reported second-quarter 2025 results on July 30, 2025, with GAAP net income applicable to common shareholders of $2.08 billiona ($7.76 per diluted share), up sharply from $301 million a year earlier.

That GAAP figure was inflated by an $893 millionb pre-tax gain (about $643 million after tax) from the sale of the Employer Voluntary Benefits business, which closed April 1, 2025. Adjusted net income, which strips out that gain along with investment gains and losses and amortization of purchased intangibles, was $1.59 billion ($5.94 per diluted share), versus $429 million ($1.61) in the prior-year quarter. Total revenues rose 5.8% to $16.6 billion.

Core property-liability underwriting improved markedly. The recorded combined ratio fell to 91.1 from 101.1, and the underlying combined ratio improved to 79.5 from 85.3, helped by lower non-catastrophe reserve development and moderating loss trends in auto. Catastrophe losses were $1.99 billionc, down 6.1%.

Protection Services revenue grew 12.2% to $867 milliond, led by Allstate Protection Plans. Total policies in force reached 208 million, up 4.2% year over year, though the figure fell sequentially after the Employer Voluntary Benefits divestiture. Management also highlighted a 9% dividend increase to $1.00 per quarter, $341 million of share repurchases, and the July 1 close of the Group Health sale, with an expected third-quarter gain of roughly $500 million.

For investors, the key takeaways are the strength of underlying margins and the portfolio repositioning, offset by some caveats. Auto and homeowners growth is improving, but homeowners results remain volatile, with a $76 million underwriting loss and a recorded combined ratio of 102.0 driven by catastrophe losses. The reported 2Q earnings are not representative of a run-rate quarter because of the divestiture gains.

Investment returns were modest, with a 1.4% quarterly total return and a $144 million net realized loss, and the company said it reduced equity and high-yield exposure to lower portfolio risk. The 8-K furnishes the earnings release and investor supplement under Item 2.02 and does not file them.

Key Highlights

  1. GAAP net income applicable to common shareholders was $2.08 billion ($7.76 per diluted share), versus $301 million in Q2 2024, boosted by an $893 million pre-tax (about $643 million after-tax) gain on the Employer Voluntary Benefits divestiture.
  2. Adjusted net income was $1.59 billion ($5.94 per diluted share), versus $429 million ($1.61) a year earlier; adjusted ROE on a trailing twelve-month basis was 28.6%, up from 21.6%.
  3. Total revenues rose 5.8% to $16.6 billion, with Property-Liability premiums earned up 7.5% to $14.3 billion.
  4. Property-Liability recorded combined ratio improved 10.0 points to 91.1, and the underlying combined ratio improved 5.8 points to 79.5, reflecting higher average premiums and favorable prior-year reserve reestimates.
  5. Auto underlying combined ratio improved to 87.8 and policy count grew 0.5%, though new business growth of 24.8% was offset by New York and New Jersey restrictions; homeowners still posted a $76 million underwriting loss with $1.6 billion in catastrophe losses.
  6. Protection Services revenue rose 12.2% to $867 million, driven by Allstate Protection Plans international growth; Arity posted a larger adjusted loss of $8 million.
  7. Book value per share rose to $82.40 from $62.14, the Q2 dividend increased 9% to $1.00 per share, and $341 million of common stock was repurchased; the Group Health sale closed July 1, with an approximately $500 million gain expected in Q3 2025.

Frequently Asked Questions

  1. Why is GAAP net income so much higher than adjusted net income this quarter?

    The GAAP figure includes an $893 million pre-tax gain from the sale of the Employer Voluntary Benefits business, which closed April 1, 2025. Allstate excludes this non-recurring gain, along with net investment gains and losses and purchased-intangible amortization, to arrive at adjusted net income of $1.59 billion, which better reflects ongoing operations.

  2. Is Allstate's underwriting profitability improving on a sustainable basis?

    Partly. The underlying combined ratio improved to 79.5 from 85.3, and auto margins strengthened materially. However, part of the improvement came from favorable prior-year non-catastrophe reserve reestimates of $415 million in auto alone, and homeowners results remain volatile and sensitive to catastrophe losses, so investors should watch whether margins hold in quarters with fewer favorable reestimates.

  3. What is the impact of the divestitures on Allstate's go-forward business?

    The sales of Employer Voluntary Benefits (closed April 1, 2025) and Group Health (closed July 1, 2025) cut Health and Benefits premiums and contract charges by about 50% year over year, and total divestiture proceeds for the segment reached $3.25 billion. Management says the capital will be redeployed toward growth in property-liability and protection businesses, which should shift the company's earnings mix toward those segments.

  4. How did the investment portfolio perform, and are there risks to watch?

    The $77.4 billion portfolio generated $754 million of net investment income, up $42 million year over year, and a 1.4% total return for the quarter. However, Allstate recorded $144 million of net realized losses, mainly from fixed income sales, and performance-based income fell to $79 million from $107 million. Management reduced public equity and high-yield exposure and shortened duration to lower portfolio risk.